Cargando…

In-silico analysis of the inhibition of the SARS-CoV-2 main protease by some active compounds from selected African plants

OBJECTIVES: Over the years, Azadirachta indica, Mangifera indica, and Moringa oleifera have been shown to possess some antiviral characteristics. This study applies molecular docking techniques to assess inhibitory effects of some bioactive compounds from the plants mentioned above against the main...

Descripción completa

Detalles Bibliográficos
Autores principales:	Umar, Haruna I., Josiah, Sunday S., Saliu, Tolulope P., Jimoh, Tajudeen O., Ajayi, Adeola, Danjuma, Jamilu B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taibah University 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787523/ https://www.ncbi.nlm.nih.gov/pubmed/33437230 http://dx.doi.org/10.1016/j.jtumed.2020.12.005

Ejemplares similares

Molecular docking studies of some selected gallic acid derivatives against five non-structural proteins of novel coronavirus
por: Umar, Haruna Isiyaku, et al.
Publicado: (2021)

Novel Molecules derived from 3-O-(6-galloylglucoside) inhibit Main Protease of SARS-CoV 2 In Silico
por: Umar, Haruna Isiyaku, et al.
Publicado: (2021)

Plant-derived compounds effectively inhibit the main protease of SARS-CoV-2: An in silico approach
por: Mahmud, Shafi, et al.
Publicado: (2022)

Flavonoid compounds of buah merah (Pandanus conoideus Lamk) as a potent SARS-CoV-2 main protease inhibitor: in silico approach
por: Umar, Abd. Kakhar
Publicado: (2021)

In silico evaluation of Philippine Natural Products against SARS-CoV-2 Main Protease
por: Cheng, Adrian Josiah T., et al.
Publicado: (2022)

In silico targeting SARS-CoV-2 spike protein and main protease by biochemical compounds
por: Babaeekhou, Laleh, et al.
Publicado: (2021)

In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (M(pro))
por: Falade, Victoria Adeola, et al.
Publicado: (2021)

In silico approach for identification of natural compounds as potential COVID 19 main protease (M(pro)) inhibitors
por: Chaturvedi, Monika, et al.
Publicado: (2021)

Molecular docking and pharmacokinetic studies of phytocompounds from Nigerian Medicinal Plants as promising inhibitory agents against SARS-CoV-2 methyltransferase (nsp16)
por: Saliu, Tolulope Peter, et al.
Publicado: (2021)

In silico screening of antiviral compounds from Moringa oleifera for inhibition of SARS-CoV-2 main protease
por: Sivani, Bala Mohan, et al.
Publicado: (2021)

An in-silico evaluation of COVID-19 main protease with clinically approved drugs
por: Tachoua, Wafa, et al.
Publicado: (2020)

Statins and the COVID-19 main protease: in silico evidence on direct interaction
por: Reiner, Željko, et al.
Publicado: (2020)

Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
por: Rangsinth, Panthakarn, et al.
Publicado: (2021)

In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease
por: Ram, Thrigulla Saketh, et al.
Publicado: (2022)

In silico identification of natural compounds against SARS-CoV-2 main protease from Chinese herbal medicines
por: Kuang, Yi, et al.
Publicado: (2023)

An in-silico investigation of potential natural polyphenols for the targeting of COVID main protease inhibitor
por: Aljarba, Nada H., et al.
Publicado: (2022)

In silico assessment of diterpenes as potential inhibitors of SARS-COV-2 main protease
por: Abdelrady, Yousef A, et al.
Publicado: (2023)

Therapeutic capability of five active compounds in typical African medicinal plants against main proteases of SARS-CoV-2 by computational approach
por: Abodunrin, Oluwasayo Peter, et al.
Publicado: (2022)

In Silico Identification and Validation of Organic Triazole Based Ligands as Potential Inhibitory Drug Compounds of SARS-CoV-2 Main Protease
por: Sur, Vishma Pratap, et al.
Publicado: (2021)

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
por: Teli, Divya M., et al.
Publicado: (2021)

In-silico screening of naturally derived phytochemicals against SARS-CoV Main protease
por: Mostafa, Islam, et al.
Publicado: (2021)

Acridone Alkaloids: In-Silico Investigation Against SARS-CoV-2 Main Protease
por: Oderinlo, Ogunyemi Olajide, et al.
Publicado: (2022)

In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus
por: Eleftheriou, Phaedra, et al.
Publicado: (2020)

Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease
por: Hemmati, Seyed Ali, et al.
Publicado: (2022)

Synthesis and In Silico Study of Some New bis-[1,3,4]thiadiazolimines and bis-Thiazolimines as Potential Inhibitors for SARS-CoV-2 Main Protease
por: Gomha, Sobhi M., et al.
Publicado: (2022)

Hordatines as a Potential Inhibitor of COVID-19 Main Protease and RNA Polymerase: An In-Silico Approach
por: Dahab, Mohammed A., et al.
Publicado: (2020)

Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences
por: Narkhede, Rohan R., et al.
Publicado: (2020)

2-Phenoxyacetamide derivatives as SARS-CoV-2 main protease inhibitor: In silico studies
por: Hariyono, Pandu, et al.
Publicado: (2022)

Apigenin analogues as SARS-CoV-2 main protease inhibitors: In-silico screening approach
por: Farhat, Ameny, et al.
Publicado: (2022)

In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor
por: Wen, Lei, et al.
Publicado: (2021)

Screening, molecular simulation & in silico kinetics of virtually designed covid-19 main protease inhibitors
por: Aleissa, Mohammed S., et al.
Publicado: (2022)

Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease
por: Elkaeed, Eslam B., et al.
Publicado: (2022)

In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
por: Gao, Menghan, et al.
Publicado: (2023)

In silico detection of inhibitor potential of Passiflora compounds against SARS-Cov-2(Covid-19) main protease by using molecular docking and dynamic analyses
por: Yalçın, Serap, et al.
Publicado: (2021)

In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (M(pro))
por: Alesawy, Mohamed S., et al.
Publicado: (2021)

Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS-CoV-2 main protease (M(pro)): DFT, QSAR, molecular docking, and in silico toxicity analysis
por: Mohapatra, Ranjan K., et al.
Publicado: (2021)

In silico analysis of selected alkaloids against main protease (M(pro)) of SARS-CoV-2
por: Garg, Saksham, et al.
Publicado: (2020)

In silico fight against novel coronavirus by finding chromone derivatives as inhibitor of coronavirus main proteases enzyme
por: Sepay, Nayim, et al.
Publicado: (2020)

Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target
por: Ortega, Joseph Thomas, et al.
Publicado: (2020)

In Silico Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease
por: Yañez, Osvaldo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hksljbtpshae1m6l50jra82g3j